Schistosoma infection,KRAS mutation status,and prognosis of colorectal cancerOA北大核心CSTPCD
Schistosoma infection,KRAS mutation status,and prognosis of colorectal cancer
Xinyi Li;Kailin Cai;Xiu Nie;Xiaona Chang;Hongli Liu;Bo Huang;Ming Yang;Jun Fan;Jiwei Zhang;Mixia Weng;Zhecheng Yan;Li Liu
Department of Pathology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430022,ChinaDepartment of Gastrointestinal Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430022,ChinaCancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430022,China||Hubei Key Laboratory of Precision Radiation Oncology,Wuhan,Hubei 430022,China||Institute of Radiation Oncology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430022,ChinaDepartment of Epidemiology and Biostatistics,The Ministry of Education Key Lab of Environment and Health,School of Public Health,Huazhong University of Science and Technology,Wuhan,Hubei 430022,China
《中华医学杂志（英文版）》 2024 (002)
235-237 / 3
This work was supported by grants from the National Key Research and Development Program of China(Nos.2022YFF1203300 and 2018YFC1313300),the National Natural Science Foundation of China(Nos.81702392 and 81472707),the Chinese South Western Oncology Group(No.CSWOG-CCET005),and the Beijing Bethune Public Welfare Foundation(No.BJ-GYQZHX2021006).
评论